Results 191 to 200 of about 28,326 (256)

Sensitivity of circulating tumor DNA in advanced mycosis fungoides: A retrospective case series. [PDF]

JAAD Int
DeSimone J, Kuchimanchi N, Al-Mondhiry J, Jang S.   +3 more
europepmc   +1 more source

Sensitivity and prognostic significance of circulating tumor DNA (ctDNA) in stage I to III malignant melanoma. [PDF]

J Cancer Res Clin Oncol
Bohne AS, Heber M, Axt F, von Bubnoff N, Kähler K.   +4 more
europepmc   +1 more source

BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88^L265P-induced PIM1 stability. [PDF]

J Hematol Oncol
Yuan Y, Dai B, Zhong H, Zheng J, Fan Z, Chen D, Wang Q, Wu H, Li Y, Zhu P, Ding T, Wang S, Wu K, Zhang Y, Wang Z, Feng R, Zhu F, Zheng K, Qin Z, Yang B, Chen H, Lin X, Yao Y, Zhuang D, Shi Z, Mao Y, Chen T.   +26 more
europepmc   +1 more source

Circulating tumor DNA and prognosis in gastric cancer patients undergoing surgery: meta-analysis and trial sequential analysis. [PDF]

Front Oncol
Bian J, Liu J.
europepmc   +1 more source

AR and Beyond: ctDNA Maps Resistance Evolution in mCRPC. [PDF]

Clin Cancer Res
Chauhan PS, Pachynski RK, Maher CA, Chaudhuri AA.   +3 more
europepmc   +1 more source

CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients. [PDF]

J Neurooncol
Arjuna S, Pirhoushiaran M, Bueno A, Sanchez-Espitia A, Tavakkol E, Khalaj K, Shah M, Wang I, Balar AP, Dono A, Duose D, Nguyen S, Kamali A, Luthra R, Patel CB, Prabhu SS, Lang FF, Esquenazi Y, Ballester LY.   +18 more
europepmc   +1 more source

Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial. [PDF]

JCO Precis Oncol
Armstrong AJ, Saad F, Oya M, Shore N, Procopio G, Arslan C, Mehra N, Brown E, Joung JY, Sugimoto M, Özgüroğlu M, Gedye C, Sartor O, Poehlein C, Qiu P, Liu YZ, Li X, Harrington EA, McGuinness D, Kang J, Barnicle A, Clarke N.   +21 more
europepmc   +1 more source

Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial. [PDF]

Clin Cancer Res
Bianchini G, Malorni L, Caputo R, Zambelli A, Puglisi F, Bianchi GV, Del Mastro L, Paris I, Montemurro F, Colleoni M, Allegrini G, Tamberi S, Zamagni C, Cazzaniga ME, Orditura M, Guarneri V, Adamo V, Romagnoli E, Valerio MR, Cinieri S, Benelli M, Callari M, Valsecchi D, Castelletti D, Grasso D, Fenderico N, Arpino G, De Laurentiis M.   +27 more
europepmc   +1 more source

Circulating tumor DNA as a prognostic biomarker in adjuvant nivolumab therapy for high-risk muscle-invasive urothelial carcinoma: insights from CheckMate 274 and beyond. [PDF]

Transl Androl Urol
Yajima S, Masuda H.
europepmc   +1 more source